✦ LIBER ✦

Schedule dependent cytotoxicity of bortezomib and melphalan in multiple myeloma

✍ Scribed by Popat, Rakesh; Maharaj, Lenushka; Oakervee, Heather; Cavenagh, Jamie; Joel, Simon

Book ID: 119827000
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 146 KB
Volume: 160
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12089

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib plus Melphalan and Prednisone

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

✍ San Miguel, Jesús F.; Schlag, Rudolf; Khuageva, Nuriet K.; Dimopoulos, Meletios 📂 Article 📅 2008 🏛 Massachusetts Medical Society 🌐 English ⚖ 356 KB

Salvage and Hematopoietic Recovery With

Salvage and Hematopoietic Recovery With Bortezomib and Melphalan In Cytopenic Recurrent and Refractory Multiple Myeloma

✍ A. Mazumder; D. Vesole; S. Jagannath 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Bortezomib-Melphalan-Prednisone-Thalidom

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

✍ Palumbo, A.; Bringhen, S.; Larocca, A.; Rossi, D.; Di Raimondo, F.; Magarotto, V 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 253 KB

Gamma-secretase inhibitor enhances the c

Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma

✍ Feng Chen; Alexandra Pisklakova; Ming Li; Rachid Baz; Daniel M. Sullivan; Yulia 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 369 KB

Bortezomib, melphalan, prednisone (VMP)

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study

✍ Morabito, Fortunato; Bringhen, Sara; Larocca, Alessandra; Wijermans, Pierre; Vic 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

Blockade of interleukin-6 signalling wit

Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma

✍ Sally A. Hunsucker; Valeria Magarotto; Deborah J. Kuhn; Steven M. Kornblau; Mich 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 584 KB